ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer

International Journal of Cancer

Volumn 127, Issue 4, 2010, Pages 820-829

  Liu, Lili ^a   Zhang, Hongbo ^b   Sun, Li ^b   Gao, Yuqi ^c   Jin, Haifeng ^b   Liang, Shuhui ^b   Wang, Yanxia ^a   Dong, Mingqing ^a   Shi, Yongquan ^b   Li, Zhichao ^a   Fan, Daiming ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Hypoxia; Hypoxia inducible factor 1; MAPK; MGr1 Ag 37LRP

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1; LAMININ; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 37; MITOGEN ACTIVATED PROTEIN KINASE 1; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VINCRISTINE; 1,3 BUTADIENE DERIVATIVE; ENZYME INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MGR1 ANTIGEN, HUMAN; MGR1-ANTIGEN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRILE; OXIDIZING AGENT; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL ADHESION; CELL HYPOXIA; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH MUCOSA; TRANSIENT TRANSFECTION; WESTERN BLOTTING; ANIMAL; ANOXIA; CELL MOTION; DRUG ANTAGONISM; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL CULTURE;

ANIMALS; ANOXIA; ANTIGENS, NEOPLASM; APOPTOSIS; BLOTTING, WESTERN; BUTADIENES; CELL ADHESION; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; OXIDANTS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 77954715664     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25098     Document Type: Article

References (43)

1. Comerford KM, Cummins EP, Taylor CT. c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor1α-dependent P-glycoprotein expression in hypoxia. Cancer Res 2004;15:9057-61.
2. Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 1998;8:588-94.
3. Gradin K, McGuire J, Wenger RH, Kvietikova I, Whitelaw ML, Toftgård R, Tora L, Gassmann M, Poellinger L. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the ARNT transcription factor. Mol Cell Biol 1996;16:5221-31.
4. Semenza GL. HIF-1α: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000;88:1474-80.
5. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-iducible factor 1. Mol Cell Biol 1996;16:4604-13.
6. Papandreou I, Krishna C, Kaper F, Cai D, Giaccia AJ, Denko NC. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res 2005;65:3171-8.
7. Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev 1994;13:139-68.
8. Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. Br J Cancer 2003;89:2133-9.
9. Yokoi K, Fidler IJ. Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by Gemcitabine. Clin Cancer Res 2004;10:2299-306.
10. Li J, Shi M, Cao Y, Yuan W, Pang T, Li B, Sun Z, Chen L, Zhao RC. Knockdown of hypoxia-inducible factor-1α in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate. Biochem Biophys Res Commun 2006;342:1341-51.
11. Yang DI, Chen SD, Yang YT, Ju TC, Xu JM, Hsu CY. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1. Br J Pharmacol 2004;141:988-96.
12. Liu L, Ning X, Sun L, Shi Y, Guo C, Han S, Liu J, Han Z, Sun S, Wu KC, Fan D. Hypoxia-inducible factor-1α contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 2008;99:121-8.
13. Shi Y, Zhai H, Wang X, Wu H, Ning X, Han Y, Zhang D, Xiao B, Wu K, Fan D. Multidrug- resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor. Cell Mol Life Sci 2002;59:1577-83.
14. Shi Y, Han Y, Wang X, Zhao Y, Ning X, Xiao B, Fan D. MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells. Gastric Cancer 2002;5:154-9.
15. Sun L, Shi Y, Guo C, Yao L, Lin T, Du J, Han Q, Han Y, Fan D. Regulation of multidrug resistance by MGr1-Ag in gastric cancer cells. Tumor Biol 2006;27:27-35.
16. Sun L, Liu L, Shi Y, Guo C, Pan Y, Lin T, Du Y, Wang X, Han S, Chen Y, Guo Y, Liu Z, et al. Cell adhesion to laminin enhences acquired chemotherapeutic drugs resistance (CAM-DR) mediated by MGr1-Ag/37LRP in gastric cancer. JCMM (under review).
17. Liu L, Sun L, Zhang H, Ning X, Sun S, Guo C, Han S, Chen Y, Wu K, Fan D. Hypoxia-Mediated Up-Regulation of MGr1-Ag/37LRP in gastric cancers occurs via hypoxia-inducible-factor 1-dependent mechanism and contributes to drug resistance. Int J Cancer 2009;124:1707-15.
18. Berra E, Milanini J, Richard DE, Le Gall M, Viñals F, Gothié E, Roux D, Pagès G, Pouysségur J. Signaling Angiogenesis via p42/p44 MAP Kinase and Hypoxia. Biochem Pharmacol 2000;60:1171-8.
19. Minet E, Arnould T, Michel G, Roland I, Mottet D, Raes M, Remacle J, Michiels C. ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett 2000;468:53-8.
20. Zhang Q, Oh CK, Messadi DV, Duong HS, Kelly AP, Soo C, Wang L, Le AD. Hypoxia- induced HIF-1 α accumulation is augment in a co-culture of keliod fibroblasts and human mast cells: Involvement of ERK1/2 and PI-3K/Akt. Exp Cell Res 2006;312:145-55.
21. Blaschke F, Stawowy P, Goetze S, Hintz O, Gräfe M, Kintscher U, Fleck E, Graf K. Hypoxia activates β1-integrin via ERK 1/2 and p38 MAP kinase in human vascular smooth muscle cells. Biochem Biophys Res Commun 2002;29:890-6.
22. Lester RD, Jo M, Campana WM, Gonias SL. Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem 2005;280:39273-7.
23. Risbud MV, Guttapalli A, Albert TJ, Shapiro IM. Hypoxia activates MAPK activity in rat nucleus pulposus cells: regulation of integrin expression and cell survival. Spine 2005;15:2503-9.
24. Ossum CG, Wulff T, Hoffmann EK. Regulation of the mitogen-activated protein kinase p44 ERK activity during anoxia/recovery in rainbow trout hypodermal fibroblasts. J Exp Biol 2006;209:1765-76.
25. Liu C, Shi Y, Du Y, Ning X, Liu N, Huang D, Liang J, Xue Y, Fan D. Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK. Exp Cell Res 2005;309:410-8.
26. Griffiths EA, Pritchard SA, Welch IM, Price PM, West CM. Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer 2005;41:2792-805.
27. Wartenberg M, Ling FC, Müschen M, Klein F, Acker H, Gassmann M, Petrat K, Pütz V, Hescheler J, Sauer H. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor sepheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J 2003;17:503-15.
28. Wartenberg M, Gronczynska S, Bekhite MM, Saric T, Niedermeier W, Hescheler J, Sauer H. Regulation of multidrug resistance transporter P-glycoprotein in multicellular prostate tumor sepheroids by hyperthermia and reactive oxygen species. Int J Cancer 2005;113:229-40.
29. Li M, Fan D, Zhou S, Ren J, Chen Z. Preparation and identification of monoclonal antibody associated with gastric cancer multidrug resistance (in Chinese with English abstract). Mod Oncol 1995;3:143-5.
30. Taylor CT, Furuta GT, Synnestvedt K, Colgan SP. Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc Natl Acad Sci USA 2000;97:12091-6.
31. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 2002;277:27975-81.
32. Harris AL. Hypoxia: a key regulatory factor in tumor growth. Nat Rev Cancer 2002;2:38-47.
33. Fan D, Zhang X, Chen X, Mou Z, Hu J, Zhou S, Ding J, Wu K. Bird's-eye view on gastric cancer research of the past 25 years. J Gastroenterol Hepatol 2005;20:360-5.
34. Fan DM, Xiao B, Shi YQ, Feng M, Qiao TD, Chen BJ.Chen Z. A novel cDNA fragment associated with gastric cancer drug resistance was screened out from a library by monoclonal antibody MGr1. World J Gastroenterol 1998;4S2:110-1.
35. Han Y, Shi Y, Zheng Y, Nie Y, Zhang M, Pan B. MGr1-Ag associated drug-resistant phenotype is regulated by protein kinase C (in Chinese with English abstract). Hua Ren Xiao Hua Tsa Chih (World Chin J Digest) 2001;9:517-21.
36. Mizukami Y, Fujiki K, Duerr EM, Gala M, Jo WS, Zhang X, Chung DC. Hypoxic regulation of vascular endothelial growth factor through the induction of PI3K/Rho/ROCK and c-Myc. J Biol Chem 2006;16:1-19.
37. Lee KH, Choi EY, Hyun MS, Kim JR. Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell lines, PC3MLN4. Exp Mol Med 2004;1:57-64.
38. Lee E, Yim S, Lee SK, Park H. Two transactivation domains of hypoxia-inducible factor-1alpha regulated by the MEK-1/p42/p44 MAPK pathway. Mol Cells 2002;14:9-15.
39. Zhou J, Callapina M, Goodall GJ, Brüne B. Functional integrity of nuclear factor kappaB, phosphatidylinositol 3′-kinase, and mitogen-activated protein kinase signaling allows tumor necrosis factor alpha-evoked Bcl-2 expression to provoke internal ribosome entry site- dependent translation of hypoxia-inducible factor 1alpha. Cancer Res 2004;64:9041-8.
40. Lee SM, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG. Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathway in lung cancer cells. Cancer Lett 2005;4:1-8.
41. Moon SK, Kang SK, Kim CH. Reactive oxygen species mediates disialoganglioside GD3-induced inhibition of ERK1/2 and matrix metalloproteinase-9 expression in vascular smooth muscle cells. FASEB J 2006;20:1387-95.
42. Kefaloyianni E, Gaitanaki C, Beis I. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal 2006;18:2238-51.
43. Emerling BM, Platanias LC, Black E, Nebreda AR, Davis RJ, Chandel NS. Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol Cell Biol 2005;25:4853-62.